Prudential Financial’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$878K Buy
153,970
+15,770
+11% +$68.2K ﹤0.01% 1696
2026
Q1
$535K Sell
138,200
-55,900
-29% -$229K ﹤0.01% 1842
2025
Q4
$811K Buy
194,100
+173,720
+852% +$672K ﹤0.01% 1677
2025
Q3
$67K Sell
20,380
-108,005
-84% -$305K ﹤0.01% 2310
2025
Q2
$182K Sell
128,385
-76,801
-37% -$109K ﹤0.01% 2225
2025
Q1
$306K Buy
+205,186
New +$323K ﹤0.01% 1979
2023
Q4
Sell
-136,530
Closed -$194K 2698
2023
Q3
$194K Buy
+136,530
New +$194K ﹤0.01% 2399

Other funds holding PGEN

Prudential Financial's PGEN Position: Q2 2026 in Review

Prudential Financial increased its Precigen (PGEN) stake by 11% in Q2 2026, buying an estimated $68.2K and bringing the position to 153,970 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #1696.

Prudential Financial first reported a position in PGEN in Q3 2023 and has held it in 7 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Prudential Financial held 153,970 shares of Precigen worth $878K as of Q2 2026.
  • Prudential Financial bought 15,770 Precigen shares in Q2 2026, an estimated $68.2K.
  • Precigen made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1696 holding.
  • Prudential Financial first reported a position in Precigen in Q3 2023 and has held it in 7 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.